DNTH
Dianthus Therapeutics, Inc.
Stock
$88.21−0.11 (−0.12%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $23M
- YoY, 2025
- +76.8%
- 5-year CAGR
- +18.1%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $23M | +76.8% |
| 2024 | $13M | +344.6% |
| 2023 | $2.9M | +91.0% |
| 2022 | $1.5M | −85.3% |
| 2021 | $10M | +3.7% |
| 2020 | $9.9M | −0.6% |
| 2019 | $10M | −6.6% |
| 2018 | $11M | +373.8% |
| 2017 | $2.3M | +241.2% |
| 2016 | $662K | — |